The global patent landscape of the drugs for treating Alzheimer's disease from 2014-2023. [PDF]
BMC NeurolXu Y, Gao Y.
europepmc +1 more source
Paradoxical improvement of mitral regurgitation associated with hyperadrenocorticism-related cardiac hypertrophy in a dog with myxomatous mitral valve disease. [PDF]
Vet Res CommunNam HS, Oh Y.
europepmc +1 more source
Upfront combination therapy with sildenafil and ambrisentan in patients with chronic thromboembolic pulmonary hypertension. [PDF]
J Bras PneumolSalibe-Filho W +8 more
europepmc +1 more source
Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis of Randomized Controlled Trials. [PDF]
Endocrinol Diabetes MetabJaber D +4 more
europepmc +1 more source
Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report. [PDF]
Cancer Rep (Hoboken)Nigi A +5 more
europepmc +1 more source
Pyrazofurin Biosynthesis Involves Nonenzymatic Ring Contraction of a Pyridazine Intermediate Triggered by a Rieske Enzyme-Catalyzed Oxygenation. [PDF]
J Am Chem SocZheng Z, Lee YH, Ren D, Liu HW.
europepmc +1 more source
Crystal Structure and Conformational Dynamics of N─N Bond-Forming Piperazate Synthase. [PDF]
ChembiochemPal N +7 more
europepmc +1 more source
First example of an electropolymerizable heptazine bearing oligothiophene arms: a new way to produce well-defined heptazine-containing polymers. [PDF]
RSC AdvKulszewicz-Bajer I +3 more
europepmc +1 more source
Exploring the untapped pharmacological potential of imidazopyridazines. [PDF]
RSC AdvMalik MS +7 more
europepmc +1 more source
A Ponatinib-Associated Transcriptomic Signature: Implications for Cardiovascular Toxicity. [PDF]
Int J Mol SciKong J, Jang J, Kong JH, Lee T.
europepmc +1 more source